A Year After Yeztugo, This HIV Prevention Shot Is Changing How People Think About PrEP
One year after the FDA approved Yeztugo, the first twice-yearly injectable medication for HIV prevention, doctors are beginning to see what long-term adoption looks like beyond clinical trials. For many people considering PrEP, remembering a daily pill has long been one of the biggest hurdles. Yeztugo replaces that routine withContinue Reading










